問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2022-06-01 - 2024-12-31
Condition/Disease
Test Drug
Participate Sites12Sites
Not yet recruiting4Sites
Recruiting8Sites
2021-12-01 - 2022-12-12
Participate Sites6Sites
Recruiting6Sites
2023-08-01 - 2028-06-30
Carcinoma, Hepatocellular
Tecentriq (RO5541267) (Atezolizumab)Avastin (RO4876646) (Bevacizumab)RO7092284 (Tiragolumab)RO7247669 (PD1-LAG3)
Participate Sites5Sites
Recruiting5Sites
2022-07-06 - 2025-05-31
Not yet recruiting5Sites
Recruiting1Sites
2020-10-01 - 2021-10-01
Participate Sites1Sites
2019-07-01 - 2020-06-30
Participate Sites3Sites
Not yet recruiting1Sites
Terminated2Sites
2018-11-15 - 2025-06-30
2015-07-01 - 2016-06-30
Terminated1Sites
2020-05-01 - 2024-11-18
Chronic Hepatitis B
1.Chimpanzee adenovirus HBV vaccine, 2.Modified Vaccinia Ankara HBV vaccine, 3.HBc-HBs/AS01_B4,
2007-03-01 - 2008-05-31
Terminated5Sites
全部
